MX7533E - Procedimiento para preparar derivados de dihidropiridina - Google Patents
Procedimiento para preparar derivados de dihidropiridinaInfo
- Publication number
- MX7533E MX7533E MX8511595U MX1159585U MX7533E MX 7533 E MX7533 E MX 7533E MX 8511595 U MX8511595 U MX 8511595U MX 1159585 U MX1159585 U MX 1159585U MX 7533 E MX7533 E MX 7533E
- Authority
- MX
- Mexico
- Prior art keywords
- different
- same
- alkyl groups
- group
- groups
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59133650A JPS6112662A (ja) | 1984-06-28 | 1984-06-28 | ジヒドロピリジン誘導体及びその製法 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX7533E true MX7533E (es) | 1989-08-15 |
Family
ID=15109748
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX8511595U MX7533E (es) | 1984-06-28 | 1985-06-28 | Procedimiento para preparar derivados de dihidropiridina |
MX26687A MX26687A (es) | 1984-06-28 | 1988-07-20 | Procedimiento para la preparar derivados de dehidropiridina. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX26687A MX26687A (es) | 1984-06-28 | 1988-07-20 | Procedimiento para la preparar derivados de dehidropiridina. |
Country Status (13)
Country | Link |
---|---|
US (1) | US4727082A (es) |
EP (1) | EP0167371B1 (es) |
JP (1) | JPS6112662A (es) |
KR (1) | KR900005019B1 (es) |
AT (1) | ATE61356T1 (es) |
AU (1) | AU569161B2 (es) |
CA (2) | CA1300157C (es) |
DE (1) | DE3581967D1 (es) |
ES (3) | ES8707933A1 (es) |
GR (1) | GR851568B (es) |
MX (2) | MX7533E (es) |
PT (1) | PT80714B (es) |
SU (1) | SU1342413A3 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8503427D0 (en) * | 1985-02-11 | 1985-03-13 | Ici Plc | Basic compounds |
GB8503425D0 (en) * | 1985-02-11 | 1985-03-13 | Ici Plc | Alkanolamine derivatives |
EP0276552A1 (en) * | 1986-12-08 | 1988-08-03 | Yamanouchi Pharmaceutical Co. Ltd. | 1,4-dihydropyridine derivatives and their production |
CA1312611C (en) * | 1987-07-01 | 1993-01-12 | Yamanouchi Pharmaceutical Co., Ltd. | Pyridine derivatives, process for production thereof and pharmaceutical composition containing them |
GB9102031D0 (en) * | 1991-01-30 | 1991-03-13 | Fujisawa Pharmaceutical Co | Dihydropyridine compounds,and process for their preparation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2753946A1 (de) * | 1977-12-03 | 1979-06-13 | Bayer Ag | 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel |
US4285955A (en) * | 1978-10-31 | 1981-08-25 | Bayer Aktiengesellschaft | 1,4-Dihydropyridinecarboxylic acids |
NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
DE3207982A1 (de) * | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
HU192166B (en) * | 1982-08-06 | 1987-05-28 | Banyu Pharma Co Ltd | Process for producing 2-carbamoyl-oxy-alkyl-1,4-dihydro-pyridine derivatives |
US4500527A (en) * | 1983-06-22 | 1985-02-19 | Usv Pharmaceutical Corporation | Antihypertensive 4[(3-alkylamino-2-hydroxypropyl)-oxyiminomethyl phenyl]-1,4-dihydropyridines |
NO854021L (no) * | 1984-10-26 | 1986-04-28 | Bayer Ag | 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav. |
GB8503425D0 (en) * | 1985-02-11 | 1985-03-13 | Ici Plc | Alkanolamine derivatives |
-
1984
- 1984-06-28 JP JP59133650A patent/JPS6112662A/ja active Granted
-
1985
- 1985-06-21 AU AU43967/85A patent/AU569161B2/en not_active Ceased
- 1985-06-26 GR GR851568A patent/GR851568B/el unknown
- 1985-06-26 PT PT80714A patent/PT80714B/pt not_active IP Right Cessation
- 1985-06-27 ES ES544647A patent/ES8707933A1/es not_active Expired
- 1985-06-27 SU SU853915847A patent/SU1342413A3/ru active
- 1985-06-27 KR KR1019850004583A patent/KR900005019B1/ko not_active IP Right Cessation
- 1985-06-28 EP EP85304646A patent/EP0167371B1/en not_active Expired - Lifetime
- 1985-06-28 CA CA000485923A patent/CA1300157C/en not_active Expired - Fee Related
- 1985-06-28 AT AT85304646T patent/ATE61356T1/de not_active IP Right Cessation
- 1985-06-28 DE DE8585304646T patent/DE3581967D1/de not_active Expired - Fee Related
- 1985-06-28 MX MX8511595U patent/MX7533E/es unknown
-
1986
- 1986-02-24 ES ES552336A patent/ES8704899A1/es not_active Expired
- 1986-02-24 ES ES552335A patent/ES8704898A1/es not_active Expired
- 1986-09-17 US US06/908,350 patent/US4727082A/en not_active Expired - Fee Related
-
1988
- 1988-07-06 CA CA000571338A patent/CA1312085C/en not_active Expired - Fee Related
- 1988-07-20 MX MX26687A patent/MX26687A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JPS6112662A (ja) | 1986-01-21 |
GR851568B (es) | 1985-11-25 |
PT80714B (en) | 1986-12-11 |
ES552335A0 (es) | 1987-04-16 |
SU1342413A3 (ru) | 1987-09-30 |
ES8704899A1 (es) | 1987-04-16 |
EP0167371A2 (en) | 1986-01-08 |
CA1312085C (en) | 1992-12-29 |
MX26687A (es) | 1994-03-31 |
ES8707933A1 (es) | 1987-09-01 |
EP0167371A3 (en) | 1987-06-16 |
ATE61356T1 (de) | 1991-03-15 |
EP0167371B1 (en) | 1991-03-06 |
US4727082A (en) | 1988-02-23 |
CA1300157C (en) | 1992-05-05 |
ES544647A0 (es) | 1987-09-01 |
ES552336A0 (es) | 1987-04-16 |
KR900005019B1 (ko) | 1990-07-18 |
AU569161B2 (en) | 1988-01-21 |
ES8704898A1 (es) | 1987-04-16 |
AU4396785A (en) | 1986-01-02 |
KR860000261A (ko) | 1986-01-27 |
DE3581967D1 (de) | 1991-04-11 |
JPH0123463B2 (es) | 1989-05-02 |
PT80714A (en) | 1985-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI850140L (fi) | Kemiska foereningar. | |
DE69514367D1 (de) | Substituierte amidderivate | |
BR9815377A (pt) | Derivados de sulfonil | |
BR9713417A (pt) | Composto de açúcar, agente gelificante, composição de agente gelificante, processos para suas preparações e composição de gel. | |
EP0902007A4 (en) | CHALCON DERIVATIVES AND MEDICINES THAT CONTAIN THEM | |
EA200000677A1 (ru) | Фунгицидная смесь на базе амидных соединений и производных пиридина | |
NO161564C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater. | |
IS5588A (is) | Æxliseyðandi miðlar | |
MX7533E (es) | Procedimiento para preparar derivados de dihidropiridina | |
FR2672801B1 (fr) | Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese. | |
ES2091489T3 (es) | Derivados de imidazol y composiciones farmaceuticas que los contienen. | |
KR880002828A (ko) | 디하이드로피리딘 유도체 및 이것의 약학적 조성말 | |
NO159927C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aromatiske aminoacetylener. | |
AU557533B2 (en) | Oxadithiadiaza, dioxaselenadiaza, dioxatelluradiaza, and dioxathiadiaza-2,5-pentalene derivatives | |
KR920006317A (ko) | 칼슘 흡수 억제제 | |
NO168580C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-furanethanaminer | |
PT84367B (pt) | Processo para a preparacao de uma composicao fungicida contendo uma naftimidazolona | |
RU95102788A (ru) | Производные бензоилхинолина, их кислотноаддитивные соли и комплексы солей металлов и фунгицидное средство на их основе | |
KR890016023A (ko) | 1-디메틸카바모일-3-치환된-5-치환된-1h-1,2,4-트리아졸, 이를 함유한 조성물 및 그 사용방법 | |
ES2053808T3 (es) | Nuevos compuestos azolicos. | |
DK84785D0 (da) | Kinatsalte af antimalariaforbindelsen mefloquin | |
SE8500963D0 (sv) | Nitraminodiaryl sulfoxide derivatives, process for their preparation and pharmaceutical and pesticidal compositions containing them |